Literature DB >> 10748291

Establishment and characterization of HKESC-1, a new cancer cell line from human esophageal squamous cell carcinoma.

Y Hu1, K Y Lam, T S Wan, W Fang, E S Ma, L C Chan, G Srivastava.   

Abstract

The establishment of an esophageal cancer cell line can facilitate the search for molecular mechanisms involved in esophageal carcinogenesis. A new human cancer cell line, HKESC-1, was established from a primary moderately-differentiated squamous cell carcinoma of the esophagus from a 47-year-old Hong Kong Chinese man. The pathological characteristics (morphology, immunohistochemical, and electron microscopic studies), the tumorigenecity in nude mice, the cytogenetic features, the DNA ploidy, and telomerase activity of the cell line were investigated. The HKESC-1 cells have been maintained continuously in vitro for more than 16 months and passaged over 96 times. HKESC-1 cells grow as a monolayer, with a doubling time of 46 hours. The HKESC-1 cells are of a squamous epithelial origin, as shown by their immunopositivity with the anti-cytokeratin antibodies and ultrastructural demonstration of tonofilaments and desmosomes. The HKESC-1 cells possess characteristics of malignancy because they are highly tumorigenic in nude mice and have strong telomerase activity. The HKESC-1 cells had an aneuploid DNA content, as demonstrated by flow cytometric analysis. Cytogenetic analysis revealed hyperdiploidy of greater than 50 in 80% of analyzable metaphases. Chromosome gains and losses were common, and loss of the Y chromosome was a consistent numerical aberration. Additionally, many structural chromosomal abnormalities were encountered, with frequent breakpoints at 1p32, 7p22, 7q34, and 20q13. This newly established cell line serves as a useful model for studying the molecular pathogenesis, and testing new therapeutic reagents for esophageal squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748291     DOI: 10.1016/s0165-4608(99)00193-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  15 in total

1.  Authentication of newly established human esophageal squamous cell carcinoma cell line (YM-1) using short tandem repeat (STR) profiling method.

Authors:  Khosravi Ayyoob; Khoshnia Masoud; Kazeminejad Vahideh; Asadi Jahanbakhsh
Journal:  Tumour Biol       Date:  2015-10-02

2.  Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma.

Authors:  Marco K C Hui; Kenneth K Y Lai; Kwok Wah Chan; John M Luk; Nikki P Lee; Yvonne Chung; Leo C Cheung; Gopesh Srivastava; Sai Wah Tsao; Johnny C Tang; Simon Law
Journal:  Med Oncol       Date:  2011-11-16       Impact factor: 3.064

3.  Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.

Authors:  Yi Ren; Simon Law; Xin Huang; Ping Yin Lee; Michael Bacher; Gopesh Srivastava; John Wong
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

4.  The pathogenesis of Barrett's esophagus: secondary bile acids upregulate intestinal differentiation factor CDX2 expression in esophageal cells.

Authors:  Yingchuan Hu; Valerie A Williams; Oliver Gellersen; Carolyn Jones; Thomas J Watson; Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

5.  Preclinical evaluation of afatinib (BIBW2992) in esophageal squamous cell carcinoma (ESCC).

Authors:  Chi Hang Wong; Brigette Buig Yue Ma; Connie Wun Chun Hui; Qian Tao; Anthony Tak Cheung Chan
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

6.  Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma.

Authors:  Marco K C Hui; Kenneth K Y Lai; Kwok Wah Chan; John M Luk; Nikki P Lee; Yvonne Chung; Leo C M Cheung; Gopesh Srivastava; Sai Wah Tsao; Johnny C Tang; Simon Law
Journal:  Med Oncol       Date:  2012-04-19       Impact factor: 3.064

7.  Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage.

Authors:  Marco K C Hui; Kwok Wah Chan; John M Luk; Nikki P Lee; Yvonne Chung; Leo C M Cheung; Gopesh Srivastava; Sai Wah Tsao; Johnny C Tang; Simon Law
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

8.  Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy.

Authors:  Wen Wen Xu; Bin Li; Alfred K Y Lam; Sai Wah Tsao; Simon Y K Law; Kwok Wah Chan; Qiu Ju Yuan; Annie L M Cheung
Journal:  Oncotarget       Date:  2015-01-30

9.  Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization.

Authors:  Jiangchao Li; Xiaodong Li; Yan Li; Hong Yang; Lijing Wang; Yanru Qin; Haibo Liu; Li Fu; Xin-Yuan Guan
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

10.  Establishment and characterization of three new human breast cancer cell lines derived from Chinese breast cancer tissues.

Authors:  Chao Shen; Meijia Gu; Dan Liang; Lixia Miao; Liu Hu; Congyi Zheng; Jiakuan Chen
Journal:  Cancer Cell Int       Date:  2009-01-02       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.